BIODYNE Inside Director Yang Geun-ho Slightly Increases Stake to 0.06% via Open Market Purchases

BIODYNE registered inside director Yang Geun-ho acquired an additional 3,000 common shares through open market purchases on July 9 and 10, 2026.
The acquisition prices were 9,087 KRW and 8,824 KRW per share, totaling approximately 26.7 million KRW.
This purchase increased his holdings from 15,000 to 18,000 shares, raising his stake from 0.05% to 0.06%.
Although small in scale, voluntary insider buying can be interpreted as a positive signal of management commitment to shareholder value.
[AI Summary]This minor insider share purchase has limited impact on short-term stock price but signals increased insider confidence. No changes in capital structure or dividend policy were reported.